These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7883388)

  • 41. Empiric carbapenem monotherapy in pediatric bone marrow transplant recipients.
    Nelson WK; Rayback PA; Quinones R; Giller RH
    Ann Pharmacother; 2002 Sep; 36(9):1360-5. PubMed ID: 12196052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lucasti et al in the May 2008 issue of Clinical Therapeutics.
    Porath AD
    Clin Ther; 2008 Oct; 30(10):1934; author reply 1934-6. PubMed ID: 19014850
    [No Abstract]   [Full Text] [Related]  

  • 43. Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin.
    Bauer SL; Wall GC; Skoglund KJ; Peters LK
    J Allergy Clin Immunol; 2004 Jan; 113(1):173-5. PubMed ID: 14713926
    [No Abstract]   [Full Text] [Related]  

  • 44. Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections.
    Chang DC; Wilson SE
    Am J Surg; 1997 Sep; 174(3):284-90. PubMed ID: 9324138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Carbapenems in pediatrics].
    Aujard Y
    Arch Pediatr; 1996; 3 Suppl 1():298s-301s. PubMed ID: 8796048
    [No Abstract]   [Full Text] [Related]  

  • 46. Bacteriological study of 28 patients with intraabdominal infection in Japan.
    Ito Y; Kato N; Kato H; Watanabe K
    J Infect Chemother; 2000 Sep; 6(3):168-72. PubMed ID: 11810559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monobactams and carbapenems for treatment of intraabdominal infections.
    Brismar B; Nord CE
    Infection; 1999; 27(2):136-47. PubMed ID: 10219648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI; Fung CP; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
    Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
    Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S
    Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune response in patients with intra-abdominal infections treated with carbapenems.
    Brismar B; Eklund AE; Nord CE
    Int J Clin Pharmacol Res; 1994; 14(3):111-4. PubMed ID: 7883388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbapenems: monotherapy in intra-abdominal sepsis.
    Wilson SE
    Scand J Infect Dis Suppl; 1995; 96():28-33. PubMed ID: 7652500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changing role of carbapenems in the treatment of lower respiratory tract infections.
    Lode H; Hamacher J; Eller J; Schaberg T
    Scand J Infect Dis Suppl; 1995; 96():17-23. PubMed ID: 7652498
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.